Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
600056.SS
BUYGet insider-trade alertsChina Meheco Group Co., Ltd. · Healthcare · China · $1.9B · Avg Vol: $18M/d
COMPANY DESCRIPTION
China Meheco Group Co., Ltd. is a state-owned pharmaceutical enterprise with a vertically integrated business model spanning drug R&D, manufacturing, and international trade and distribution. The company serves as a vital channel for importing foreign pharmaceuticals and medical devices into China, supported by its extensive national distribution network. Its strong regulatory relationships and global supply chain capabilities form a robust competitive moat.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 5.5B | 5.7B | 5.2B | 5.2B | -2.0% | 5.2B |
| EPS | 0.07 | 0.10 | 0.06 | 0.05 | -13.7% | 0.05 |
| Shares | 1.5B | 1.5B | 1.5B | 1.5B | 0.0% | 1.5B |
| Debt | 792.4M | 827.8M | 949.5M | 774.6M | -0.8% | 815.4M |
| Equity | 1.6B | 1.7B | 1.8B | 1.7B | 3.1% | — |
| Op CF | 242.4M | 126.5M | 149.0M | 210.0M | -4.7% | 217.5M |
| Inv CF | 3.3M | -46.6M | -54.0M | -44.1M | — | — |
| Fin CF | -0.3M | -106.9M | -24.2M | -236.3M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600056.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 600056.SS | China Meheco Group Co., Ltd.(you) | $1.9B | 80 | BUY |
| 301015.SZ | Qingdao Baheal Medical INC. | $1.5B | 86 | STRONG BUY |
| 600998.SS | Jointown Pharmaceutical Group Co., Ltd | $3.4B | 80 | BUY |
| 0874.HK | Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited | $2.9B | 85 | STRONG BUY |
| 000028.SZ | China National Accord Medicines Corporation Ltd. | $1.7B | 96 | STRONG BUY |
| 600511.SS | China National Medicines Corporation Ltd. | $2.9B | 98 | STRONG BUY |
| 600739.SS | Liaoning Cheng Da Co., Ltd. | $2.2B | 56 | HOLD |
| 603368.SS | Guangxi LiuYao Group Co., Ltd | $854M | 92 | STRONG BUY |
| 000950.SZ | C.Q. Pharmaceutical Holding Co., Ltd. | $1.3B | 51 | HOLD |
| 2607.HK | Shanghai Pharmaceuticals Holding Co., Ltd | $5.5B | 97 | STRONG BUY |
Peer medians: ROE 4.8% · P/E 26.5x · Gross margin 52.5%